Marker Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update Executed comprehensive non-dilutive agreement with Cell ReadyTM, resulting in an extended financial runway into the fourth quarter of 2025 Appointed Juan Vera, M.D. as President and Chief Executive...